1RASOUL S, OTTERVANGER J P, BOER M J, et al. Primary percutaneous coronary intervention for ST-elevation myocardial infarction; From clinical trial to clinical practice [J]. Intern J Cardiol, 2009, 134: 104-109.
2JULIARD J M, CHARLIER P, GOLMARD J L, et al. Age and lack of β-hlocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarction[J]. Intern J Cardiol, 2003, 88: 63-68.
3HALKIN A, GRINES C L, COX D A, et al. Impact of intravenous beta-blocker before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction [J]. JACC, 2004,43:1780 -1787.
4MILLER C D, MULGUND J, HOEKSTRA J W,et al. Patterns and correlates of acute (24 hours) use of beta-blockers for non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE initiative[J]. Ann Emergen Med, 2005,46 :S59-60.
5WANG F W,OSMAN A,OTERO J, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary β-blocker[J]. Circulation , 2003,107:2914 - 2919.
6KERNIS S J, HARJAI K J, STONE G W, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? [J]. JACC, 2004,43: 1773-1779.
7FAXON D P. Editorial comment. Beta-blocker therapy and primary angioplasty what is the controversy? [J]. JACC ,2004,43:1789-1790.
8CHAN AW, QUINN M J, BHATT D L, et al. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention[J]. JACC, 2002, 40:669-675.
9ELLIS S G, SCHNEIDER J P, TOPOL E J. Comparison of long-term survival following non-Q wave creatine kinase elevation after percutaneous coronary intervention in patients discharged on a beta blocker versus those not so treated[J]. Am J Cardiol, 2002, 89:751-753.
10JABER W A, LENNON R J, MATHEW V, et al. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator[J]. JACC, 2005,46:1473- 1478.
同被引文献9
1Antman EM, Aabe DT, Armstrong PW, et al. ACC/AHA guide- lines for the management of patients with ST-elevation myocardial infarction-executive summary [ J ]. J Am Coll Cardiol, 2004,44 (3) : 671 -719.
2Rasoul S, Ottervanger JP, Boer M J, et al. Primary percutaneous coronary intervention for ST-elevation myocardial infarction from clinical trial toc linical practice[ J]. Intern J Cardiol,2009,134: 104-109.
3Wang FW, Osman A, Otero J, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker [ J ]. Circulation, 2003,107: 2914 - 2919.
4Miller CD, Mulgund J, Hoekstra JW, et al. Patterns and correlates of acute(24 hours)use of beta-blockers for non-ST-segment ele- vation acute coronary syndromes:Results from the CRUSAD Eini- tiative [ J ]. Ann Emergen Med,2005,46: 59 - 60.
5Faxon DP. Editorial comment. Beta-blocker therapy and primary angioplasty what is the controversy [ J ]. JACC, 2004,43:1789 - 1790.
